Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06233318 · ClinicalTrials.gov registry record · NA
Sternotomy PIFB Block in Open Heart Surgery
A NA study of Autonomic Nerve Block, sponsored by Ohio State University.
- Recruiting
- Registry status
- NA
- Development phase
- 84
- Enrollment target
- 1
- Study location
NCT06233318 is a NA study of Autonomic Nerve Block that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 84 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06233318, a NA study of Autonomic Nerve Block, is actively recruiting participants, sponsored by Ohio State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate if the use of a bilateral nerve block with a local anesthetic (ropivacaine), as part of a standard of care pain control regimen (called multimodal analgesia \[MMA\]), has a favorable effect on our institutional MMA pain regimen. Subjects will go through the following study procedures: review of medical history and medications subjects have taken within a month prior to surgery. Subjects will be randomly assigned to one of the two study groups (1:1) to receive either, an ultrasound-guided bilateral nerve block (called "Pecto-Intercostal Fascial Block \[PIFB\]") with ropivacaine or saline 0.9 solution, in addition to our institutional MMA regimen. A baseline line pain and nausea scores will be recorded before surgery. The block will be performed right after general anesthesia induction. The details about the surgery will be collected. Pain assessments, nausea and vomiting scores will be registered at 12, 24 and 48 hours after surgery as well. Lastly, a follow up phone call will be made by the research team to conduct a pain-detect questionnaire at 30, 60 and 90 days after surgery.
Conditions Studied
Interventions
- PROCEDURE Pecto-intercostal Fascial Block with 20 ml of 0.35% ropivacaine
- PROCEDURE Pecto-intercostal Fascial Block with normal saline
Study Locations (1)
Ohio
- The Ohio State University Wexner Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2023-10-16 |
| Est. Completion | 2027-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06233318
The ClinicalTrials.gov registry entry for NCT06233318 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Autonomic Nerve Block appearing as the primary indexed condition, and to 2 interventions - of which Pecto-intercostal Fascial Block with 20 ml of 0.35% ropivacaine is the first listed.
NCT06233318 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT06233318 about?
NCT06233318 is a clinical study titled "Sternotomy PIFB Block in Open Heart Surgery". The purpose of this study is to evaluate if the use of a bilateral nerve block with a local anesthetic (ropivacaine), as part of a standard of care pain control regimen (called multimodal analgesia \[MMA\]), has a favorable effect on our institutional MMA pain regimen. Subjects will go through the f...
What is the current status of trial NCT06233318?
This trial is currently recruiting. It is a NA study. The enrollment target is 84 participants. The study started on 2023-10-16. Estimated completion is 2027-01-31.
What conditions does trial NCT06233318 study?
This clinical trial studies the following conditions: Autonomic Nerve Block.
What interventions are being tested in trial NCT06233318?
The interventions under investigation include: Pecto-intercostal Fascial Block with 20 ml of 0.35% ropivacaine (PROCEDURE), Pecto-intercostal Fascial Block with normal saline (PROCEDURE).
Who is sponsoring clinical trial NCT06233318?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06233318 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.